作者: Sora Han , Young Yang
DOI: 10.1007/S13765-016-0172-9
关键词: Immunity 、 Suppressor 、 Immunotherapy 、 Inflammation 、 T cell 、 Immune system 、 Biology 、 Myeloid-derived Suppressor Cell 、 Immunology 、 Population
摘要: Myeloid-derived suppressor cells (MDSCs) are originated and differentiated population from common hematopoietic progenitor cells. Generally, in the late stage of inflammation, MDSCs differentiation expansion promoted to suppress over-activated immune system so that can maintain homeostasis. Recently, it has been revealed accumulate cancer patients tumor-bearing experimental animals, these tumor-derived anti-tumor immunity by secreting immunosuppressive cytokines including reactive oxygen species inducible nitric oxide synthase. This fact prompts scientists shed light on as significant targets for anti-cancer immunotherapy. However, due morphological, phenotypic, functional heterogeneities MDSCs, is not easy develop therapeutic strategies targeting MDSCs. In this review, we will summarize recent progress defined subsets their T cell-mediated immunity.